Ms. Martin joined EXUMA Biotechnology in January 2017 as a Vice President, Finance and Controller and is responsible for the accounting and finance of the Company including the Cayman subsidiary and Asia operations. Prior to joining EXUMA Biotech, she served as Vice President, Finance and Corporate Controller of Halozyme Therapeutics, Inc., a San Diego publicly traded biotechnology company, from 2004 to 2016. She also served as Director of Finance of Ambit Biosciences from 2000 to 2003 and prior to that held various positions in the finance and accounting field. Ms. Martin began her career at Arthur Andersen where she obtained her CPA license. She earned her Bachelor of Business Administration in Accounting from the University of Texas at Austin.
Laurel MartinVP Finance & Controller